MoneyWorks4Me

Auro Laboratories - Quaterly Results

14 Aug 2025 Evaluate
The sales for the June 2025 quarter moved down -51.50% to Rs. 27.74 millions as compared to Rs. 57.20 millions during the year ago period.The Net Loss for the quarter ended June 2025 is Rs. -1.05 millions as compared to Net Profit of Rs. 7.53 millions of corresponding quarter ended June 2024Operating profit for the quarter ended June 2025 decreased to 4.50 millions as compared to 15.26 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 27.74 57.20 -51.50 27.74 57.20 -51.50 193.98 536.35 -63.83
Other Income 4.16 2.03 104.93 4.16 2.03 104.93 6.56 15.04 -56.38
PBIDT 4.50 15.26 -70.51 4.50 15.26 -70.51 40.59 121.74 -66.66
Interest 2.81 2.50 12.40 2.81 2.50 12.40 10.82 7.36 47.01
PBDT 1.69 12.76 -86.76 1.69 12.76 -86.76 29.77 114.38 -73.97
Depreciation 2.74 2.70 1.48 2.74 2.70 1.48 10.96 10.92 0.37
PBT -1.05 10.06 -110.44 -1.05 10.06 -110.44 18.81 103.46 -81.82
TAX 0.00 2.53 0.00 0.00 2.53 0.00 0.42 25.54 -98.36
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.61 -1.87 -67.38
PAT -1.05 7.53 -113.94 -1.05 7.53 -113.94 18.39 77.92 -76.40
Equity 62.32 62.32 0.00 62.32 62.32 0.00 62.32 62.32 0.00
PBIDTM(%) 16.22 26.68 -39.19 16.22 26.68 -39.19 20.92 22.70 -7.81
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..